Alzheimer's Disease: Progress in Understanding, Disappointment in Therapy
L. Michael Posey
Senile dementia of the Alzheimer type remains difficult to treat or even manage, despite advances in understanding of this frustrating disease.
Total Drug Therapy Cost Control, Part II: Minimizing Distribution
Costs
David K. Buerger
The second of our three-part series on ASCP Executive Director
R. Tim Webster's drug therapy cost control guidelines highlights
distribution cost control components of the formula.
Putting the MDS 2.0 to Work in Long-Term Care
Kathy Riley
The intense focus on resident assessment exemplified by the new
MDS 2.0 offers tremendous opportunities for consultant pharmacists
to find creative new ways to provide value-added services to long-term
care facilities.
The Face Within the Chart
Pamela Black
What happens when the information on the chart belongs to a member
of your own family? A consultant pharmacist finds that it takes
more than knowledge and professional expertise to make a difference
in an individual resident's quality of care.
 C O N T E N T S July 1996/Volume 11, Number 7 |
 |
Cost Analysis of Immediate- Versus Controlled-Release
Medication Administration in Long-Term Care
Steve Zlotnick, Theodore Prince, I. Barton Frenchman
The authors review medication administration costs as
they relate to delivery systems in long-term care facilities.
Nurses' Satisfaction with Pharmaceutical Services for Home Care Hospices
Candace L. Haugtvedt, Linda D. MacKeigan, Stephen W.
Birdwell, Donald L. Bennett
A self-administered questionnaire was used to assess the
quality of pharmaceutical services provided to hospice programs
in Columbus, Ohio.
|
Bylines R. Tim Webster
Commentary
ASCP Reports
Consultants Forum |
Subacute Care Forum Low White Blood Cell Count-Medication-Induced or Not?
Assisted Living Forum
Hospital Forum
Helpful Ideas
Late Additions |